Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
11UCB-J PET Scan
BRIGHT MINDS BIOSCIENCES INC.
Opiate Dependence
1 trial -
20 grams protein
United Therapeutics Europe Ltd
Muscle Disuse
1 trial -
25% Carbohydrate solution (CHO drinking)
Hospital Authority, Hong Kong
Type2diabetes
1 trial -
30% Nitrous oxide
BRIGHT MINDS BIOSCIENCES INC.
Opioid-Related Disorders
2 trials -
3T MR Imaging of the cervical spinal cord
United Therapeutics Europe Ltd
Cervical Spondylosis With Myelopathy
1 trial -
89Zr-trastuzumab
United Therapeutics Europe Ltd
Breast Cancer Metastases
1 trial -
95% condensed proanthocyanidins from grape seed extract
United Therapeutics Europe Ltd
Iron Deficiency Anemia
1 trial -
99mTc-4BOH SPECT myocardial perfusion imaging
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
99mTc-pyrophosphate Scintigraphy
Alnylam Netherlands B.V.
Transthyretin Amyloidosis
1 trial -
A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose 72 hours postoperatively.
The First People's Hospital of Lianyungang
Anal Fistula
1 trial -
A single step culture medium
Universal Integrated
ICSI
1 trial -
A+ HA(tm)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
2 trials -
AIM-CHD Mobile Health Intervention
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Secondary Prevention of Coronary Heart Disease
1 trial -
ANKASCIN 568-P Red yeast rice capsules
Biotech Pharmaceutical Co.,
Hyperlipidemias
1 trial -
AVN944
Vertex Pharmaceuticals (Australia) Pty.
Refractory Solid Tumors
1 trial -
Abbreviated non-contrast MRI of the liver
Hospital Authority, Hong Kong
Hepatocellular Carcinoma
1 trial -
Abciximab local infusion
Atrium Therapeutics
Acute Anterior Myocardial Infarction
1 trial -
Accelerated partial breast irradiation
Universal Integrated
Breast Cancer
1 trial -
Accurate Prediction Artificial Intelligence Models
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Adjustment of Antiplatelet Drugs
The First People's Hospital of Lianyungang
Intracranial Aneurysm
1 trial -
Albumin Human
United Therapeutics Europe Ltd
Burn Injury
1 trial -
Albuterol
The First People's Hospital of Lianyungang
Chronic Obstructive Pulmonary Disease
1 trial -
Albuterol eMDPI DS
Teva Pharma GmbH
Pulmonary Disease, Chronic Obstructive
1 trial -
Allergy immunotherapy ("allergy shots")
United Therapeutics Europe Ltd
Eosinophilic Esophagitis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources